Description
Added on the 28/08/2020 14:00:00 - Copyright : EFE Inglés
Mainz (Germany), 10 Nov (EFE/EPA) - (Camera: Ronald Wittek) The American pharmaceutical company Pfizer and the German company BioNTech announced Monday that their experimental vaccine against covid-19 shows an effectiveness of more than 90% in the participants without previous evidence of infection, more than required by the US regulators and even than expected by their directors.FOOTAGE OF BIONTECH'S HEADQUARTERS IN MAINZ, GERMANY
Hosingen (Luxembourg), Feb 17 (EFE), (Camera: EFE).- The distribution, storage and conservation of the Covid-19 vaccines vials that are being distributed in the EU, such as those from Pfizer or Moderna, is a real logistical challenge since they require extremely low temperatures (-20 and -70 Celsius degrees, respectively).This challenge has made many companies essential, such as the freezers manufacturer B Medical Systems in Luxembourg.FOOTAGE OF B MEDICAL SYSTEMS.
FDA Commissioner Scott Gottlieb said that in November Pfizer offered the Trump Administration more COVID-19 vaccines. Gottlieb says the Trump administration rejected the offer. The NY Times reports that Pres. Trump rejected 100 million doses of Pfizer's recently approved COVID-19 vaccine over the summer. According to Business Insider the COVID-19 vaccine deployment campaign started Monday, December 14th.
An FDA advisory committee will meet next month to discuss an emergency use authorization. The emergency use authorization would be for Pfizer's COVID-19 vaccine. Earlier this week, Pfizer said clinical trials had shown its vaccine to be 95% effective. "While we cannot predict how long the FDA's review will take, the FDA will review the request as expeditiously as possible, while still doing so in a thorough and science-based manner," FDA Commissioner Stephen M. Hahn In October, the Emergency Care Research Institute warned against releasing a vaccine. They said six months of follow-up data on clinical trial participants is needed to move forward.
There are currently two COVID-19 vaccines promising results from their Phase 3 trials. Moderna announced that its vaccine was 94.5% effective. Pfizer/BioNTech announced that their vaccine was 95% effective. How long will it take for all Americans to be vaccinated? If the FDA approves the vaccine, Business Insider says first responders and vulnerable populations will receive vaccines through March. A new analysis from Morgan Stanley predict it will take four to nine months to vaccinate the general U.S. population.
|
Support : Technical 
- Content 
- Editors 
